[Medical_Sciences] The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer
28th Dec 2005, 00:41 GMT
The most devastating aspect of cancer is the emergence of metastases. Thus, identification of potentially metastatic cells among a tumor cell population and the underlying molecular changes that switch cells to a metastatic state are among the most important issues in cancer biology. Here we show that, although normal human colonic epithelial cells lack the glycosphingolipid globotriaosylceramide (Gb3), this molecule is highly expressed in metastatic colon cancer. In addition, a subpopulation of cells that are greatly enriched in Gb3 and have an invasive phenotype was identified in human colon cancer cell lines. In epithelial cells in culture, Gb3 was necessary and sufficient for cell invasiveness. Transfection of Gb3 synthase, resulting in Gb3 expression in noncancerous polarized epithelial cells lacking endogenous Gb3, induced cell invasiveness. Furthermore, Gb3 knockdown by small inhibitory RNA in colon cancer epithelial cells inhibited cell invasiveness. Gb3 is the plasma membrane receptor for Shiga toxin 1. The noncatalytic B subunit of Shiga toxin 1 causes apoptosis of human colon cancer cells expressing Gb3. Injections of the B subunit of Shiga toxin 1 into HT29 human colon cancer cells engrafted into the flanks of nude mice inhibited tumor growth. These data demonstrate the appearance of a subpopulation of Gb3 containing epithelial cells in the metastatic stage of human colon cancer and suggest their possible role in colon cancer invasiveness.
[Medical_Sciences] The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer related news:
- Chicken May Cut Colon Cancer Risk — WebMD Health Headlines
- More Colon Cancer Patients Get Chemotherapy (HealthDay) — Yahoo! Health: Chemotherapy News
- Chicken Cuts Colon Cancer Risk — Health News: CBSnews.com
- NICE guidance in development on docetaxel use in prostate cancer — OnMedica Latest News
- Vitamin D lowers cancer risk: study (Reuters) —
- Vitamin D lowers cancer risk - study — KeralaNext: Latest News
- Gene Discovery Could Broaden Cancer Research (HealthDay) — Yahoo! Health: Prostate Cancer News
- In N.H., a cancer victim spawns legacy — Boston Globe -- City/Region News
- New study shows Vitamin D lowers cancer risk — MSNBC.com: Health
- Vitamin D Needed To Cut Cancer Risk, Researchers Say — ScienceDaily Headlines: Health & Medicine
Latest news from Proceedings of the National Academy of Sciences recent issues:
- [Commentary] Hedgehogs like it sweet, too
- [Commentary] Germ cells carry the epigenetic benefits of grandmother's diet
- [Commentary] Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?
- [Nobel] War and peace
- [Cell_Biology] Inaugural Article: Podocin and MEC-2 bind cholesterol to regulate the activity of associated ion channels
- [Introductory_Perspective] Nitrogen Fixation Special Feature: Reduction of dinitrogen
- [Perspective] Nitrogen Fixation Special Feature: How many metals does it take to fix N2? A mechanistic overview of biological nitrogen fixation
- [Chemistry] Nitrogen Fixation Special Feature: Inner-sphere two-electron reduction leads to cleavage and functionalization of coordinated dinitrogen
- [Chemistry] Nitrogen Fixation Special Feature: Catalytic reduction of dinitrogen to ammonia at a single molybdenum center
- [Chemistry] Nitrogen Fixation Special Feature: On the feasibility of N2 fixation via a single-site FeI/FeIV cycle: Spectroscopic studies of FeI(N2)FeI, FeIVN, and related species